These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29596987)

  • 1. Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review.
    Ma C; Hussein IM; Al-Abbar YJ; Panaccione R; Fedorak RN; Parker CE; Nguyen TM; Khanna R; Siegel CA; Peyrin-Biroulet L; Pai RK; Vande Casteele N; D'Haens GR; Sandborn WJ; Feagan BG; Jairath V
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1407-1419.e22. PubMed ID: 29596987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set.
    Ma C; Panaccione R; Fedorak RN; Parker CE; Nguyen TM; Khanna R; Siegel CA; Peyrin-Biroulet L; D'Haens G; Sandborn WJ; Feagan BG; Jairath V
    Clin Gastroenterol Hepatol; 2018 May; 16(5):637-647.e13. PubMed ID: 28843356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review: outcomes and adverse events from randomised trials in Crohn's disease.
    Catt H; Hughes D; Kirkham JJ; Bodger K
    Aliment Pharmacol Ther; 2019 Apr; 49(8):978-996. PubMed ID: 30828852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D; Macdonald JK; Chande N
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M; Naidoo K; Thomas AG; Akobeng AK
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008414. PubMed ID: 21249709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Crohn's disease Clinical Trial Endpoints based upon Different Cutoffs for Patient Reported Outcomes or Endoscopic Activity: Analysis of EXTEND Data.
    Feagan B; Sandborn WJ; Rutgeerts P; Levesque BG; Khanna R; Huang B; Zhou Q; Maa JF; Wallace K; Lacerda A; Thakkar RB; Robinson AM
    Inflamm Bowel Dis; 2018 Apr; 24(5):932-942. PubMed ID: 29668919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A network meta-analysis on the efficacy of 5-aminosalicylates, immunomodulators and biologics for the prevention of postoperative recurrence in Crohn's disease.
    Yang Z; Ye X; Wu Q; Wu K; Fan D
    Int J Surg; 2014; 12(5):516-22. PubMed ID: 24576593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic Review.
    Ma C; van Rhijn BD; Jairath V; Nguyen TM; Parker CE; Aceves SS; Furuta GT; Gupta SK; Katzka DA; Safroneeva E; Schoepfer AM; Straumann A; Spergel JM; Pai RK; Feagan BG; Hirano I; Dellon ES; Bredenoord AJ
    Clin Gastroenterol Hepatol; 2018 Nov; 16(11):1714-1729.e3. PubMed ID: 29908360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
    Khanna R; Preiss JC; MacDonald JK; Timmer A
    Cochrane Database Syst Rev; 2015 May; (5):CD007572. PubMed ID: 25942580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW; Bickston SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine for induction of remission in Crohn's disease.
    McDonald JW; Feagan BG; Jewell D; Brynskov J; Stange EF; Macdonald JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD000297. PubMed ID: 15846602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natalizumab for induction of remission in Crohn's disease.
    Macdonald JK; McDonald JW
    Cochrane Database Syst Rev; 2006 Jul; (3):CD006097. PubMed ID: 16856112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natalizumab for induction of remission in Crohn's disease.
    MacDonald JK; McDonald JW
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006097. PubMed ID: 17253580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IOIBD technical review on endoscopic indices for Crohn's disease clinical trials.
    Vuitton L; Marteau P; Sandborn WJ; Levesque BG; Feagan B; Vermeire S; Danese S; D'Haens G; Lowenberg M; Khanna R; Fiorino G; Travis S; Mary JY; Peyrin-Biroulet L
    Gut; 2016 Sep; 65(9):1447-55. PubMed ID: 26353983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease.
    Rutgeerts P; Gasink C; Chan D; Lang Y; Pollack P; Colombel JF; Wolf DC; Jacobstein D; Johanns J; Szapary P; Adedokun OJ; Feagan BG; Sandborn WJ
    Gastroenterology; 2018 Oct; 155(4):1045-1058. PubMed ID: 29909019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
    Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
    World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC; Hanauer S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic Severity Predicts Long-Term Prognosis in Crohn's Disease Patients with Clinical Remission.
    Naganuma M; Hisamatsu T; Matsuoka K; Kiyohara H; Arai M; Sugimoto S; Mori K; Nanki K; Ohno K; Mutaguchi M; Mizuno S; Bessho R; Nakazato Y; Hosoe N; Inoue N; Iwao Y; Ogata H; Kanai T
    Digestion; 2016; 93(1):66-71. PubMed ID: 26789838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis.
    Ford AC; Bernstein CN; Khan KJ; Abreu MT; Marshall JK; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):590-9; quiz 600. PubMed ID: 21407179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.